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 Colorectal cancer is the second leading cause of 
cancer related death in the United States, and the sec-
ond most prevalent cancer worldwide [1]. Half of the 
patients diagnosed with colorectal cancer eventually 
die from the disease; and only less than ten percent 
of patients with the metastatic cancer survive more 
than five years after diagnosis [1]. Although in its early 
stages the cancer can be cured by surgical resection 
alone, very often surgery is combined with adjuvant ra-
dio- and chemotherapy. Patients treated for advanced 
stage colorectal cancer with adjuvant chemotherapy 
show a 40% reduced risk of relapse [2]. Recently, 
controlled clinical trials support a multimodal, multi-
disciplinary approach to treating both early stage and 
advanced colorectal cancers [3, 4].  
While advances continue to be made in developing 
effective treatment strategies for colorectal cancer pa-
tients, chemotherapies are still limited by severe side 
effects and dose-limiting toxicity. The drug-related 
adverse events not only worsen patients’ quality of life, 
but can also lead to their refusal to continue the poten-
tially curative chemotherapy [5]. Patients with cancer 
often resort to complementary and alternative medical 
means to treat the side effects of chemotherapy [6].
Ganoderma lucidum (or “Lingzhi” in Chinese) has 
long been recognized by Chinese medical profession-
als as a valuable herbal medicine in treating a number 
of different illnesses [7]. Shizhen Li, a highly influential 
doctor in Chinese medicine from the Ming Dynasty 
(1368–1644 A.D.), recorded the effectiveness of Lingzhi 
in his famous book, Ban Chao Gang Moo (“Comprehen-
sive Pharmacopoeia”), and stated that taking Lingzhi 
over the long-term would build a strong, healthy body 
and assure longevity. Ganoderma lucidum is often an 
important ingredient in traditional Chinese medicine 
herbal formulations for immune dysfunction related ill-
nesses [7, 8].
Currently, there are several Ganoderma lucidum 
herbal products available. SunRecome is a commonly 
used Ganoderma lucidum product manufactured by 
Shanghai Green Valley Pharmaceuticals in China. 
Previous studies showed that this herbal product 
could attenuate chemotherapy-induced nausea and 
vomiting in clinical trials [9] and animal studies [10]. 
Although human observational data in Chinese lit-
erature suggest that Ganoderma lucidum possesses 
an anticancer property [9], and the active anti tumor 
constituents are thought to be on the polysaccharides 
[11], the effects of this medicinal mushroom on human 
colorectal cancer cells has not been evaluated. In the 
present study, we investigated the antiproliferative 
effects of two fractions of SunRecome, i.e., a fraction 
containing mainly polysaccharides, and a triterpenoid 
fraction without polysaccharides, using SW 480 human 
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colorectal cancer cell line. Potential antioxidant activity 
of Ganoderma lucidum was also evaluated.
MATERIALS ANd METHOdS
Ganoderma lucidum extract (GLE) and test 
solution preparation. SunRecome, or Ganoderma 
lucidum extract (GLE), from one lot, was obtained from 
Shanghai Green Valley Pharmaceuticals, China. The 
extract was analyzed by Shanghai Allsuccess Com-
modity Inspection Co., who reported that the extract 
contained 1.89% terpenoids and 15.8% polysaccha-
rides using spectrophotometric methods.  Fig. 1 shows 
the chemical structure of terpenoids in Ganoderma 
lucidum. The extract was also analyzed by Applied 
Consumer Services (Hialeah Gardens, USA) to confirm 
that it was free of contamination such as microorgan-
isms, pesticide residues, and toxic elements.
Fig. 1. General structure of terpenoids in Ganoderma lucidum
Two different solutions were used to prepare GLE-1 
(a fraction containing mainly polysaccharides) and GLE-2 
(a fraction containing triterpenoids without polysac-
charides). To prepare GLE-1, the extract powder was 
dissolved in 5% ethanol-water solution and placed in a 
4 °C refrigerator over night. The following day the sealed 
sample was heated in a water bath at 80 °C for 30 min. 
When the sample temperature cool down to room tem-
perature, the solution was filtered with a Millex 0.2 µm 
nylon membrane syringe filter (Millipore Co., Bedford, 
USA).  To prepare GLE-2, the extract powder was dis-
solved in DMSO in room temperature, and then filtered 
with a Millex 0.2 µm nylon syringe filter.  To ensure that the 
cell growth was not affected by the DMSO, we studied the 
effect of DMSO alone on cell proliferation as a vehicle.
Cell culture. Human colorectal SW480 cancer cell 
line (ATCC, Manassas, USA) was maintained in Leibovitz’s 
L-15 medium with 10% L-glutamine (Gibco, USA), supple-
mented with 10% fetal bovine serum and penicillin-strep-
tomycin (50 units/ml, Invitrogen, USA), in a humidified 
incubator (5% CO2 in air at 37 °C) with medium change 
every 2–3 days.  When the cells reach 70–80% confluency, 
they were trypsinized, harvested, and seeded into a new 
tissue culture dish (100 mm in diameter).
Cell proliferation assay. On selected days after 
removal of incubation medium, SW480 cell monolayer 
was washed twice with phosphate buffered saline (PBS). 
To examine the antiproliferation effect of the extract, 
the cells were seeded in a 24-well plate at about 10,000 
cells/well with regular medium and allowed to adhere for 
24 h. After adhesion of the cells, the culture medium was 
changed prior to the addition of the test herbal extracts. 
The cells were incubated with testing material at various 
concentrations for 72 h. Control cultures were incubated 
in culture medium alone. At the end of treatments, the 
cells were detached using trypsin and counted using a 
Coulter Counter (Counlter Electronics, Hialeah, USA) 
[12, 13]. All assays were performed at least three times. 
The inhibition of SW480 cell proliferation was calculated 
as follows: Cell proliferation (%) = 100 x (each cell num-
ber in experimental well/total cell number in the control 
well).
3H-thymidine incorporation assay. SW 480 cells 
were seeded in a 24-well plate and allowed to adhere 
for 24 h. The cells were incubated with GLE-1 at various 
concentrations in 300 µl media containing 1 λ/ml 3H-thy-
midine (specific activity: 1.48 TBq /mmol 40.0 Ci/mmol) 
in each well for 72 h.  Control cultures were incubated in 
the medium with 3H-thymidine only. After washing with 
PBS and 10% TCA (trichloroacetic acid), 0.5 ml NaOH 
(0.2 M) was added to each well and agitated for 5 min. 
Finally, the cell lysates were transferred into vials and 
5 ml of 30% liquid scintillation was added and mixed in 
the vials. The radioactivity was measured using Liquid 
Scintillation Analyzer (Tri-Carb1500, Packard) [14].
Measurement of free radical scavenging ability 
of GLE-1 in a cell-free system. Antioxidant activity 
of Ganoderma lucidum was evaluated on the basis 
of its scavenging effect of DPPH radical using ESR 
spectroscopy [15]. Conventional ESR spectra were 
obtained with a Varian E-109 X-band spectrometer. 
ESR signals were recorded with 10 mW for DPPH, and 
100 kHz field modulations of 2G. All measurements 
were performed at room temperature.
The DPPH stable radical scavenging activity of GLE-1 
was estimated by ESR according to the method of Yama-
guchi et al. [16]. The reaction mixture contained 50 µl test 
sample and 50 µl DPPH solution (0.5 mM). The proportion 
of ethanol/water in the reaction mixture was 5/95. ESR 
signaling was recorded at room temperature. Time depen-
dence of the scavenging effect was determined by adding 
GLE-1 to the reaction mixture at 5 mg/ml for 2–15 min after 
mixing sample. Scavenging effect was determined by 
comparison with a control group. The dose dependency 
of the scavenging effect was also determined after GLE-1 
addetion to the reaction mixture for 15 min. 
GLE-2 was diluted in DMSO. Since DMSO pos-
sesses antioxidant activity, we were unable to evalu-
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ate the free radical scavenging ability of GLE-2 in the 
cell-free system.
Statistical analysis. Data are expressed as mean ± 
standard error (S.E.). Statistical analysis was performed 
using ANOVA in combination with Student’s t-test. Dif-
ferences were considered significant if P < 0.05.
RESULTS
Inhibitory effect of GLE-1 on SW 480 cells. The 
inhibitory activity of GLE-1 on the proliferation of SW 
480 human colorectal cancer cells at 72 h is shown in 
Fig. 2, a. GLE-1 decreased cell proliferation significantly 
in a concentration related manner. Compared to con-
trol group (100%), GLE-1 reduced cell proliferation by 
3.8 ± 4.5% at 0.05 mg/ml, 8.9 ± 5.2% at 0.25 mg/ml 
(P < 0.05), and 10.2 ± 5.0% at 1 mg/ml (P < 0.05).
Fig. 2.  Antiproliferative effects of Ganoderma lucidum extract on 
SW 480 colorectal cancer cells after 72 h treatment.  (a) Effects 
of GLE-1.  (b) Effects of GLE-2.  * P < 0.05; ** P < 0.01.
Inhibitory effect of GLE-2 on SW 480 cells. The 
inhibitory activity of GLE-2 on the proliferation of SW 
480 cells at 72 h is shown in Fig. 2, b. GLE-2 decreased 
the cell proliferation significantly in a concentration 
dependent manner. Compared to the control group, 
GLE-2 reduced cell proliferation by 18.1 ± 3.1% at 
0.05 mg/ml (P < 0.05), 40.2 ± 3.7% at 0.25 mg/ml (P 
< 0.01), and 76.7 ± 1.8% at 1 mg/ml (P < 0.01). 
Fig. 3. Time- and concentration-dependent inhibitory effects of 
Ganoderma lucidum extract on SW 480 colorectal cancer cells. 
GLE-2 was used in this experiment.  * P < 0.05; ** P < 0.01.
Fig. 3 shows the time and concentration related 
inhibitory effects of GLE-2 on the proliferation of SW 
480 cells.
Fig. 4.  Effects of Ganoderma lucidum extract on DNA synthesis. 
3H-thymidine incorporation in SW 480 colorectal cancer cells was 
measured after 72 h of treatment. ** P < 0.01
 Effects of GLE-1 on DNA synthesis by measur-
ing 3H-thymidine incorporation. As shown in Fig. 4, 
c, treatment with GLE-1 for 72 h at 0.5 and 1 mg/ml 
suppressed cellular incorporation of 3H-thymidine 
significantly by 70.0 ± 0.6% and 73.0 ± 1.5% ompared 
with the control (both P < 0.01), respectively. 
Free radical scavenging ability of GLE-1 in cell-
free system. The radical scavenging activities of 
GLE-1 in a cell free system are shown in Fig. 5. Addi-
tion of GLE-1 to the DPPH system at a concentration 
of 5mg/ml remarkably reduced the free radical ESR 
signal after 2 min. After 15 min, the ESR signal of 
DPPH was totally eliminated. This time-related effect is 
shown in Fig. 5, a. The concentration-related scaveng-
ing effect of GLE-1 for 15 min is shown in Fig 5,  b.  
Fig. 5.  Effects of Ganoderma lucidum extract on the ESR spectra 
of the DPPH radical in ethanol/water (20/80) solution.  ESR time 
points (b) spectra of the DPPH radical with GLE-1 are shown for 
different, and at different concentrations (a) 
dISCUSSION
Ganoderma lucidum is a commonly used herbal 
medicine in many Oriental countries. The anticancer 
effects of polysaccharides extracted from another 
species of genus Ganoderma were initially reported 
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in 1971 [17]. Recently, some researchers observed 
that triterpenoids in Ganoderma lucidum also are ac-
tive antitumor constituents [18, 19].  
In this study, two different solutions were used in the 
preparation of GLE-1 and GLE-2.  Although both of the 
extracts showed inhibitory effects on the proliferation 
of SW 480 human colorectal cancer cells, the percent-
age of inhibition was different, with much stronger 
inhibition using GLE-2. GLE-1 was prepared with 5% 
ethanol-water solution, which presumably dissolved 
mostly polysaccharides and a small percentage of ter-
penoids, while GLE-2 was prepared with DMSO, which 
presumably dissolved mostly terpenoids without any 
polysaccharides [11]. Thus, it seems that terpenoids 
in the GLE exert significant antiproliferative effects on 
the colorectal cancer cells in our experiments. In order 
to explore the possible mechanisms of Ganoderma 
lucidum’s anticancer activity, we evaluated the effect 
of the extract on the incorporation of 3H-thymidine in 
SW480 cells by using 3H-thymidine labeling assay. 
Our data suggest that the extract directly inhibits the 
synthesis of DNA in the cells [14].
Many herbal medicines possess antioxidant prop-
erties [20]. Antioxidants are compounds that protect 
cells against the damaging effects of reactive oxygen 
species (ROS). Some ROS, such as superoxide and 
hydrogen peroxide, are normally produced in cells as 
by-products of biochemical reactions or as signaling 
molecules. When ROS-generating reactions are acti-
vated excessively, pathological quantities of ROS are 
released to create an imbalance between antioxidants 
and ROS, resulting in cellular damage. Oxidative stress 
was linked with the pathogenesis of many human 
diseases including cancer, aging, and atheroscle-
rosis [21]. Herbal antioxidants may protect against 
these diseases by contributing to the total antioxidant 
defense system of the human body [20, 22]. We ob-
served the antioxidant effect of Ganoderma lucidum 
extract in our ESR study. The relationship between the 
observed antioxidant activity and the antiproliferation 
effect of SW 480 cells remain to be elucidated. In future 
investigations, we will also use a panel of cell lines to 
provide us with the opportunity to evaluate whether the 
effects of a medicinal herb can be generalized across 
the spectrum of human cancers.  
In addition to its possible anticancer effect, Gano-
derma lucidum may also help in decrease chemo-
therapy-induced side effects. We have demonstrated 
that the extract of Ganoderma lucidum attenuated 
cisplatin-induced nausea and vomiting in a rat model 
[10]. Cancer patients are known to use herbal prod-
ucts more often than the general population, and thus, 
well-investigated herbal therapies can offer patients 
with a practical alternative [6]. Moreover, if synergistic 
effects between herbal medicines and chemotherapy 
agents can be identified, reduction of chemotherapy 
dose in combination with herbs can further decrease 
dose-related drug toxicity. The identification of non-
toxic anticancer herbal medicines remains an essential 
step in advancing the treatment of cancer. Data ob-
tained from our studies has the potential to advance 
treatment regimens, and improve the quality of life of 
patients suffering from colorectal cancer.
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торможение пролиферации клеток колоректального 
рака линии SW 480 Экстрактом GANODERMA LUCIDUM
Цель: для лечения заболеваний, связанных с нарушениями функционирования иммунной системы, в традиционной китайской 
медицине часто используют препараты на основе Ganoderma lucidum. В данной работе было изучено влияние экстракта Gano-
derma lucidum на клетки колоректального рака человека линии SW 480. Материалы и методы: изучали две фракции экстракта 
Ganoderma lucidum: фракцию GLE-1, содержащую полисахариды, и тритерпеноидную фракцию GLE-2. Их рост-ингибирующую 
активность определяли с помощью анализа клеточной пролиферации и по включению 3H-тимидина. Для оценки антиоксидантной 
активности использовали ЕСР-спектроскопию. Результаты: обе фракции Ganoderma lucidum подавляли пролиферацию клеток 
SW 480. Рост-ингибирующий эффект GLE-2 был более выраженным, чем фракции GLE-1.  Фракция GLE-1 подавляла синтез ДНК 
в клетках линии SW 480 и понижала уровень формирования DPPH радикалов. Выводы: экстракт Ganoderma lucidum подавляет 
пролиферацию клеток колоректального рака человека и обладает антиоксидантными свойствами. 
Ключевые слова: Ganoderma lucidum, колоректальный рак, SW 480, пролиферация, активные радикалы кислорода, DPPH 
радикалы.
